King's British Heart Foundation Centre, King's College, London, United Kingdom.
Mol Cell Proteomics. 2010 Sep;9(9):2048-62. doi: 10.1074/mcp.M110.001693. Epub 2010 Jun 15.
The vascular extracellular matrix (ECM) is essential for the structural integrity of the vessel wall and also serves as a substrate for the binding and retention of secreted products of vascular cells as well as molecules coming from the circulation. Although proteomics has been previously applied to vascular tissues, few studies have specifically targeted the vascular ECM and its associated proteins. Thus, its detailed composition remains to be characterized. In this study, we describe a methodology for the extraction of extracellular proteins from human aortas and their identification by proteomics. The approach is based on (a) effective decellularization to enrich for scarce extracellular proteins, (b) successful solubilization and deglycosylation of ECM proteins, and (c) relative estimation of protein abundance using spectral counting. Our three-step extraction approach resulted in the identification of 103 extracellular proteins of which one-third have never been reported in the proteomics literature of vascular tissues. In particular, three glycoproteins (podocan, sclerostin, and agrin) were identified for the first time in human aortas at the protein level. We also identified extracellular adipocyte enhancer-binding protein 1, the cartilage glycoprotein asporin, and a previously hypothetical protein, retinal pigment epithelium (RPE) spondin. Moreover, our methodology allowed us to screen for proteolysis in the aortic samples based on the identification of proteolytic enzymes and their corresponding degradation products. For instance, we were able to detect matrix metalloproteinase-9 by mass spectrometry and relate its presence to degradation of fibronectin in a clinical specimen. We expect this proteomics methodology to further our understanding of the composition of the vascular extracellular environment, shed light on ECM remodeling and degradation, and provide insights into important pathological processes, such as plaque rupture, aneurysm formation, and restenosis.
血管细胞外基质(ECM)对于血管壁的结构完整性至关重要,它还是血管细胞分泌产物以及来自循环系统的分子结合和保留的基质。尽管蛋白质组学之前已被应用于血管组织,但很少有研究专门针对血管 ECM 及其相关蛋白。因此,其详细组成仍有待阐明。在本研究中,我们描述了一种从人主动脉中提取细胞外蛋白并通过蛋白质组学进行鉴定的方法。该方法基于(a)有效去细胞化以富集稀有细胞外蛋白,(b)成功溶解和去糖基化 ECM 蛋白,以及(c)使用谱计数相对估计蛋白丰度。我们的三步提取方法鉴定了 103 种细胞外蛋白,其中三分之一从未在血管组织的蛋白质组学文献中报道过。特别是,三种糖蛋白(足细胞蛋白、骨硬化蛋白和聚集蛋白)首次在人主动脉中被鉴定到蛋白质水平。我们还鉴定了细胞外脂肪细胞增强结合蛋白 1、软骨糖蛋白 asporin 和先前的假设蛋白视网膜色素上皮(RPE)spondin。此外,我们的方法还允许我们根据蛋白酶及其相应降解产物的鉴定,筛选主动脉样本中的蛋白水解。例如,我们能够通过质谱法检测基质金属蛋白酶-9,并将其存在与纤维连接蛋白在临床标本中的降解联系起来。我们期望这种蛋白质组学方法能进一步了解血管细胞外环境的组成,阐明 ECM 重塑和降解,并深入了解重要的病理过程,如斑块破裂、动脉瘤形成和再狭窄。